Moolec Science S.A.
MLEC · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 521.5% | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 8.4% | -15.8% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -109.5% | -5,717% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -130% | -5,722.2% | – | – |
| EPS Diluted | -0.19 | -1.5 | -0.12 | -0.001 |
| % Growth | 87.3% | -1,150% | -14,900% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |